Stay updated on Testing BI 907828 in Solid Tumors With Ezabenlimab: Clinical Trial.
Sign up to get notified when there's something new on the Testing BI 907828 in Solid Tumors With Ezabenlimab: Clinical Trial. page.

Latest updates to the Testing BI 907828 in Solid Tumors With Ezabenlimab: Clinical Trial. page
- Check5 days agoChange DetectedNew Revision: v3.5.4 entry is added to the study history, and the previous Revision: v3.5.3 entry is removed. This reflects an updated version in the record's history.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe page now reflects an updated ClinicalTrials.gov interface/version revision (from v3.5.2 to v3.5.3), indicating a platform release rather than a change to the underlying clinical trial record.SummaryDifference0.0%

- Check33 days agoChange DetectedPage history shows Revision: v3.5.2 in place of Revision: v3.5.0.SummaryDifference0.0%

- Check62 days agoChange DetectedRevision: v3.5.0 was added to the history, and Revision: v3.4.3 was removed.SummaryDifference0.0%

- Check69 days agoChange DetectedThe page history now lists revision v3.4.3 and removes v3.4.2, reflecting the latest update to the record.SummaryDifference0.0%

- Check91 days agoChange DetectedAdded and updated core trial status fields: Completed as the new Study Status, with Recruitment Status and updated Contacts/Locations. These changes reflect the trial's current operational state and contact information.SummaryDifference0.3%

Stay in the know with updates to Testing BI 907828 in Solid Tumors With Ezabenlimab: Clinical Trial.
Enter your email address, and we'll notify you when there's something new on the Testing BI 907828 in Solid Tumors With Ezabenlimab: Clinical Trial. page.